General Information of the Compound
Compound ID
CP0020422
Compound Name
N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]phenyl]-4-[[(E)-4-(dimethylamino)but-2-enoyl]amino]benzamide
    Show/Hide
Synonyms
HY-80013
THZ1
    Show/Hide
Structure
Formula
C31H28ClN7O2
Molecular Weight
566.065
Canonical SMILES
CN(C)C\C=C\C(=O)Nc1ccc(cc1)C(=O)Nc1cccc(Nc2ncc(Cl)c(n2)-c2c[nH]c3ccccc23)c1
    Show/Hide
InChI
InChI=1S/C31H28ClN7O2/c1-39(2)16-6-11-28(40)35-21-14-12-20(13-15-21)30(41)36-22-7-5-8-23(17-22)37-31-34-19-26(32)29(38-31)25-18-33-27-10-4-3-9-24(25)27/h3-15,17-19,33H,16H2,1-2H3,(H,35,40)(H,36,41)(H,34,37,38)/b11-6+
    Show/Hide
InChIKey
OBJNFLYHUXWUPF-IZZDOVSWSA-N
Physicochemical Property
logP
6.3305
Rotatable Bonds
9
Heavy Atom Count
41
Polar Areas
115.04
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
6
Complexity
41

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 73602827
ChEMBL ID
CHEMBL3603847
Clinical Information about the Compound
Drug 1 ( THZ1 )
Drug Name THZ1
Indication
Nasopharyngeal carcinoma
Investigative
Target(s)
Cyclin-dependent kinase 7 (CDK7)
Inhibitor